Safer sedation for seniors: study pinpoints dose for frail elderly

NCT ID NCT07467603

Completed Knowledge-focused Sponsor: The First Hospital of Hebei Medical University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 58 frail elderly patients (65+) to find the best dose of remimazolam, a sedative used for anesthesia. Researchers used a special monitor to track breathing and adjusted doses carefully. The goal is to help doctors give just enough medicine to put patients to sleep without causing breathing problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remimazolam (a short-acting sedative)
What this could lead to: If successful, this could help doctors give safer anesthesia doses to frail older adults, reducing breathing problems.
What could go wrong: This is a small, early-stage study with only 58 people. Results may not apply to all frail elderly patients or those with other health issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA INDUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA INDUCTION FRAILTY

Contacts and locations

Locations

Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, 050000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.